Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/d0/cb/0d/d0cb0de6-ff12-70cd-fba5-6720111b2cf4/mza_5543077143899086824.jpg/600x600bb.jpg

PharmaTalkRadio

Conference Forum

514 episodes

1 day ago

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

All content for PharmaTalkRadio is the property of Conference Forum and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

PharmaTalkRadio

17 minutes

1 week ago

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

About this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety.

For more information, go to IO360summit.com.